Hemoglobin levels and 30-day mortality in patients after myocardial infarction

International Journal of Cardiology

Volumn 100, Issue 2, 2005, Pages 289-292

  Lipšic, Erik ^a,b   Van Der Horst, Iwan C C ^a   Voors, Adriaan A ^a   Van Der Meer, Peter ^a,b   Nijsten, Maarten W N ^a   Van Gilst, Wiek H ^a,b   Van Veldhuisen, Dirk J ^a   Zijlstra, Felix ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

30 day mortality; Hemoglobin; Myocardial infarction

Indexed keywords

HEMOGLOBIN; CREATININE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; AGE DISTRIBUTION; AGED; ANEMIA; CARDIOVASCULAR MORTALITY; CORONARY CARE UNIT; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; HEMOGLOBIN BLOOD LEVEL; PATIENT CODING; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

EID: 17044377691     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.10.043     Document Type: Article

References (26)

1. R.S. Freudenberger, and J.L. Carson Is there an optimal hemoglobin value in the cardiac intensive care unit? Curr Opin Crit Care 9 2003 356 361
2. G. Alvarez, P.C. Hebert, and S. Szick Debate: transfusing to normal haemoglobin levels will not improve outcome Crit Care 5 2001 56 63
3. P.C. Hebert, G. Wells, M. Tweeddale, C. Martin, J. Marshall, and B. Pham Does transfusion practice affect mortality in critically ill patients? Transfusion requirements in critical care (TRICC) investigators and the Canadian Critical Care Trials Group Am J Respir Crit Care Med 155 1997 1618 1623
4. J.L. Carson, A. Duff, R.M. Poses, J.A. Berlin, R.K. Spence, and R. Trout Effect of anaemia and cardiovascular disease on surgical mortality and morbidity Lancet 348 1996 1055 1060
5. D. Zindrou, K.M. Taylor, and J.P. Bagger Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery Lancet 359 2002 1747 1748
6. H. Reinecke, T. Trey, J. Wellmann, J. Heidrich, M. Fobker, and T. Wichter Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions Eur Heart J 24 2003 2142 2150
7. N. Al Falluji, J. Lawrence-Nelson, J.B. Kostis, C.R. Lacy, R. Ranjan, and A.C. Wilson Effect of anemia on 1-year mortality in patients with acute myocardial infarction Am Heart J 144 2002 636 641
8. R.D. Langston, R. Presley, W.D. Flanders, and W.M. McClellan Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction Kidney Int 64 2003 1398 1405
9. W.C. Wu, S.S. Rathore, Y. Wang, M.J. Radford, and H.M. Krumholz Blood transfusion in elderly patients with acute myocardial infarction N Engl J Med 345 2001 1230 1236
10. J. Szachniewicz, J. Petruk-Kowalczyk, J. Majda, A. Kaczmarek, K. Reczuch, and P.R. Kalra Anaemia is an independent predictor of poor outcome in patients with chronic heart failure Int J Cardiol 90 2003 303 308
11. H. Tanner, G. Moschovitis, G.M. Kuster, R. Hullin, D. Pfiiffner, and O.M. Hess The prevalence of anemia in chronic heart failure Int J Cardiol 86 2002 115 121
12. J.S. Alpert, K. Thygesen, E. Antman, and J.P. Bassand Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
13. R.B. Weiskopf, M.K. Viele, J. Feiner, S. Kelley, J. Lieberman, and M. Noorani Human cardiovascular and metabolic response to acute, severe isovolemic anemia JAMA 279 1998 217 221
14. P.S. Levy, S.J. Kim, P.K. Eckel, R. Chavez, E.F. Ismail, and S.A. Gould Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis Am J Physiol 265 1993 H340 H349
15. A.S. Most, N.A. Ruocco Jr., and H. Gewirtz Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis Circulation 74 1986 1085 1092
16. L.N. Graham, P.A. Smith, J.B. Stoker, A.F. Mackintosh, and D.A. Mary Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction Circulation 106 2002 793 797
17. F. Metivier, S.J. Marchais, A.P. Guerin, B. Pannier, and G.M. London Pathophysiology of anaemia: focus on the heart and blood vessels Nephrol Dial Transplant 15 Suppl 3 2000 14 18
18. J.L. Carson, A. Duff, J.A. Berlin, V.A. Lawrence, R.M. Poses, and E.C. Huber Perioperative blood transfusion and postoperative mortality JAMA 279 1998 199 205
19. J.L. Sullivan Iron and the sex difference in heart disease risk Lancet 1 1981 1293 1294
20. C.E. Cooper Nitric oxide and iron proteins Biochim Biophys Acta 1411 1999 290 309
21. D.R. Gagnon, T.J. Zhang, F.N. Brand, and W.B. Kannel Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up Am Heart J 127 1994 674 682
22. D.W. Brown, W.H. Giles, and J.B. Croft Hematocrit and the risk of coronary heart disease mortality Am Heart J 142 2001 657 663
23. P.R. Kalra, A.P. Bolger, D.P. Francis, S. Genth-Zotz, R. Sharma, and P.P. Ponikowski Effect of anemia on exercise tolerance in chronic heart failure in men Am J Cardiol 91 2003 888 891
24. P.C. Hebert, G. Wells, M.A. Blajchman, J. Marshall, C. Martin, and G. Pagliarello A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group N Engl J Med 340 1999 409 417
25. H.L. Corwin, A. Gettinger, R.G. Pearl, M.P. Fink, M.M. Levy, and M.J. Shapiro Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial JAMA 288 2002 2827 2835
26. P. van der Meer, A.A. Voors, E. Lipsic, W.H. Van Gilst, and D.J. Van Veldhuisen Erythropoietin in cardiovascular diseases Eur Heart J 25 2004 285 291